Frank Takkinen
Stock Analyst at Lake Street
(1.77)
# 3,359
Out of 5,090 analysts
69
Total ratings
33.33%
Success rate
-9.7%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $30 → $40 | $33.49 | +19.44% | 2 | Dec 4, 2025 | |
| NOTV Inotiv | Maintains: Buy | $5 → $3 | $0.85 | +252.53% | 8 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $0.92 | +335.73% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $1.17 | +156.41% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $2.03 | +97.04% | 3 | Oct 28, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $7 | $8.15 | -14.11% | 6 | Oct 21, 2025 | |
| RCEL AVITA Medical | Downgrades: Hold | $8 → $4 | $3.53 | +13.31% | 1 | Oct 17, 2025 | |
| ELUT Elutia | Maintains: Buy | $8 → $6 | $0.70 | +757.14% | 4 | Sep 10, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $1.09 | +83.49% | 2 | Aug 14, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $139.74 | +7.34% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $13.53 | +77.38% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $30 | $29.30 | +2.39% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $9.26 | +51.19% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $11.51 | +30.38% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $18.18 | +43.05% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $13.67 | +119.46% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $5.69 | -12.13% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.65 | +330.11% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.86 | +168.82% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $44.87 | -33.14% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.84 | +616.42% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.40 | +67.01% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $16.62 | -27.80% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $4.02 | +123.96% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.33 | +588.17% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.34 | +2,612.31% | 2 | Jan 18, 2023 |
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $33.49
Upside: +19.44%
Inotiv
Dec 4, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.85
Upside: +252.53%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.92
Upside: +335.73%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $1.17
Upside: +156.41%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $2.03
Upside: +97.04%
Sight Sciences
Oct 21, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $8.15
Upside: -14.11%
AVITA Medical
Oct 17, 2025
Downgrades: Hold
Price Target: $8 → $4
Current: $3.53
Upside: +13.31%
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.70
Upside: +757.14%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.09
Upside: +83.49%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $139.74
Upside: +7.34%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $13.53
Upside: +77.38%
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $29.30
Upside: +2.39%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $9.26
Upside: +51.19%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $11.51
Upside: +30.38%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $18.18
Upside: +43.05%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $13.67
Upside: +119.46%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $5.69
Upside: -12.13%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.65
Upside: +330.11%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.86
Upside: +168.82%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $44.87
Upside: -33.14%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.84
Upside: +616.42%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.40
Upside: +67.01%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $16.62
Upside: -27.80%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $4.02
Upside: +123.96%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.33
Upside: +588.17%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.34
Upside: +2,612.31%